Recombinant Human CD86 Protein, C-His tag
- 
									
产品编号
KMH261
 - 
									
别名
CD86分子, B70, B7 2, B7.2, LAB72, CD28LG2, CD86 molecule [ Homo sapiens
 - 
									
规格
- 20ug
 - 50ug
 - 100ug
 - 200ug
 - 1mg
 
 
| Catalog Number | KMH261 | 
| Alias | CD86分子, B70, B7 2, B7.2, LAB72, CD28LG2, CD86 molecule [ Homo sapiens | 
| Size | 20ug, 50ug, 100ug, 200ug, 1mg | 
| Product Description | KMH261 Recombinant Human CD86 Protein, C-His tag contains the human CD86(26-247 aa) was expressed in Mammalian cells. | 
| Molecular Name | CD86 | 
| Product Introduction | (KMH261) CD86是T细胞激活的共刺激分子,在免疫应答中发挥重要作用。 | 
| Molecular Weight | 57-66 kDa | 
| Expression System | HEK293F Cells | 
| Species | Human | 
| Concentration | 联系销售经理获得最新批次的浓度 | 
| Purity | ≥95% | 
| SDS-PAGE | ![]()  | 
| Purification | Affinity Purification | 
| Uniprot ID | P42081 | 
| Storage Condition | Store the product under sterile conditions after opening at -80℃ for 12 months. Store the lyophilized powder at -20℃. Avoid repeated freeze-thaw cycles. | 
| Formulation | PBS, pH7.5 | 
| Shipping Condition | This product is shipped on ice packs or dry ice. | 
| Background | B7-1 and B7-2, together with their receptors CD28 and CTLA-4, constitute one of the dominant costimulatory pathways that regulate T- and B-cell responses. Although both CTLA-4 and CD28 can bind to the same ligands, CTLA-4 binds to B7-1 and B7-2 with a 2 - 1 fold higher affinity than CD28 and is involved in the down-regulation of the immune response. B7-1 is expressed on activated B cells, activated T cells, and macrophages. B7-2 is constitutively expressed on interdigitating dendritic cells, Langerhans cells, peripheral blood dendritic cells, memory B cells, and germinal center B cells. | 
| Endotoxin | < 0.1 EU per ug | 
| Protein Family | CD molecule | 
| Biological Activity | Immobilized Recombinant Human CD86 at 2 μg/mL (100 μL/well) can bind Recombinant Human CTLA-4 with a linearrange of 10-40 ng/mL. | 
| Product Declaration | 该产品仅供科研使用,不可直接用于人体或注射。 | 
是的,重组蛋白可以用于疫苗的开发,特别是在生产抗原性蛋白和研究免疫反应方面。
							
							
							
							
						
								0